|
Volumn 10, Issue 8, 2002, Pages 2511-2526
|
Design, synthesis and QSAR studies on N-aryl heteroarylisopropanolamines, a new class of non-peptidic HIV-1 protease inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BUTANOL;
FUNCTIONAL GROUP;
INDOLE DERIVATIVE;
PROPANOLAMINE DERIVATIVE;
PROTEINASE;
PROTEINASE INHIBITOR;
PYRROLE DERIVATIVE;
BUTYLAMINE;
MONOISOPROPANOLAMINE;
ARTICLE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG BINDING;
DRUG DESIGN;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
ENZYME ACTIVE SITE;
ENZYME ACTIVITY;
ENZYME INACTIVATION;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
NONHUMAN;
PROTEINASE INHIBITION;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
T LYMPHOCYTE;
CHEMISTRY;
DRUG EFFECT;
IC 50;
SYNTHESIS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
BUTYLAMINES;
DRUG DESIGN;
HIV PROTEASE;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
INDOLES;
INHIBITORY CONCENTRATION 50;
PROPANOLAMINES;
PYRROLES;
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0036286615
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(02)00119-0 Document Type: Article |
Times cited : (42)
|
References (29)
|